Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06118021
PHASE2

A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

This is a study of HS-20094 in participants with overweight and obesity. The main purpose is to learn more about how HS-20094 affects body weight. The study period including 4-12 weeks dose titration and 12-20 weeks maintain treatment and 6 weeks follow up.

Official title: A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HS-20094 in Overweight and Obese Subjects

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2023-10-16

Completion Date

2024-08-13

Last Updated

2026-06-04

Healthy Volunteers

Yes

Interventions

DRUG

HS-20094

Administered SC

DRUG

Placebo

Administered SC

Locations (2)

the Fourth Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China

The Fourth Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China